Tie Xu

Tie Xu


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2017 in NeuroMolecular Medicine
Verified
Journal Article
Closed access
PDF file
TLTan Li
Tan Li
YZYong-Mei Zhang
Yong-Mei Zhang
DHDong Han
Dong Han
RHRong Hua
Rong Hua
BGBing-Nan Guo
Bing-Nan Guo
TXTie Xu
Tie Xu

1 July 2018 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
LLLanxin Lü
Lanxin Lü
ADAnthony Deegan
Anthony Deegan
FMFaiza Musa
Faiza Musa
TXTie Xu
Tie Xu
YYYing Yang
Ying Yang

1 December 2017 in Brain Research
Verified
Journal Article
Closed access
XZXuemei Zong
Xuemei Zong
SWShuguang Wu
Shuguang Wu
FLFujun Li
Fujun Li
LLLanxin Lv
Lanxin Lv
DHDong Han
Dong Han
TXTie Xu
Tie Xu

19 November 2017 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
NZNingjun Zhao
Ningjun Zhao
PLPengchong Liang
Pengchong Liang
XZXiaoying Zhuo
Xiaoying Zhuo
CSChenglei Su
Chenglei Su
XZXuemei Zong
Xuemei Zong
TXTie Xu
Tie Xu
Delayed encephalopathy after acute carbon monoxide (CO) poisoning (DEACMP) is the most severe and clinically intractable complication that occurs following acute CO poisoning. Unfortunately, the mechanism ofDEACMPis still vague. Growing evidence indicates that delayed cerebral damage afterCOpoisoning is related to oxidative stress, abnormal neuro‐inflammation, apoptosis and immune‐mediated injury. Our recent report indicated that methylene blue (MB) may be a promising therapeutic agent in the prevention of neuronal cell death and cognitive deficits after transient global cerebral ischaemia (GCI). In this study, we aimed to investigate the potential ofMBtherapy to ameliorate the signs and symptoms of DEACMP. Rats were exposed to 1000 ppmCOfor 40 min. in the first step;COwas then increased to 3000 ppm, which was maintained for another 20 min. The rats were implanted with 7‐day release Alzet osmotic mini‐pumps subcutaneously under the back skin, which providedMBat a dose of 0.5 mg/kg/day 1 hr afterCOexposure. The results showed thatMBsignificantly suppressed oxidative damage and expression of pro‐inflammatory factors, including tumour necrosis factor‐α and interleukin (IL)‐1β.MBtreatment also suitably modulated mitochondrial fission and fusion, which is helpful in the preservation of mitochondrial function. Furthermore,MBdramatically attenuated apoptosis and neuronal death. Lastly, behavioural studies revealed thatMBtreatment preserved spatial learning and memory in the Barnes maze test. Our findings indicated thatMBmay have protective effects against DEACMP.

7 April 2016 in Scientific Reports
Verified
Journal Article
Open access
DZDengyue Zhang
Dengyue Zhang
NZNingjun Zhao
Ningjun Zhao
BMBin Ma
Bin Ma
YWYan Wang
Yan Wang
GZGongliang Zhang
Gongliang Zhang
TXTie Xu
Tie Xu
Transnitrosylation is an important mechanism by which nitric oxide (NO) modulates cell signaling pathways. For instance, SNO-caspase-3 can transnitrosylate the X-linked inhibitor of apoptosis (XIAP) to enhance apoptosis. XIAP is a potent antagonist of caspase apoptotic activity. Decrease in XIAP activity via nitrosylation results in SNO-XIAP-mediated caspase activation. Considering the functional liaison of procaspase-9 and XIAP, we hypothesized that procaspase-9 nitrosylates XIAP directly. Our data confirmed that cerebral ischemia-reperfusion induced XIAP nitrosylation, procaspase-9 denitrosylation and cleavage. Interestingly, the time courses of the nitrosylation of procaspase-9 and XIAP were negatively correlated, which was more prominent after cerebral ischemia-reperfusion, suggesting a direct interaction. The nitrosylation of XIAP, as well as the denitrosylation and cleavage of procaspase-9, were inhibited by DNCB, TrxR1 AS-ODNs, or TAT-AVPY treatment. Meanwhile, DNCB, TrxR1 AS-ODNs, or TAT-AVPY also inhibited the decrease in hippocampal CA1 neurons induced by ischemia-reperfusion in rats. The denitrosylation and cleavage of procaspase-9 induced by OGD/reoxygenation in SH-SY5Y cells were inhibited when cells were co-transfected with wild-type procaspase-9 and XIAP mutant (C449G). These data suggest that cerebral ischemia-reperfusion induces a transnitrosylation from procaspase-9 to XIAP via the Trx system to consequently cause apoptosis. Additionally, Cys325 is a critical S-nitrosylation site of procaspase-9.

19 July 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
XPXiaohan Peng
Xiaohan Peng
PCPanpan Chen
Panpan Chen
YZYang Zhang
Yang Zhang
KWKe Wu
Ke Wu
NJNingning Ji
Ningning Ji
RHRong Hua
Rong Hua
Aims: The basolateral amygdala (BLA) plays an integral role in anxiety disorders (such as post traumatic stress disorder) stem from dysregulated fear memory. The excitability of glutamatergic neurons in the BLA correlates with fear memory, and the afterhyperpolarization current (IAHP) mediated by small‐conductance calcium‐activated potassium channel subtype 2 (SK2) dominates the excitability of glutamatergicneurons. This study aimed to explore the effect of MPP2 interacts with SK2 in the excitability of glutamatergic neurons in the BLA and the extinction of conditioned fear in mice.Methods: Fear memory was analyzed via freezing percentage. Western blotting and fluorescence quantitative PCR were used to determine the expression of protein and mRNA respectively. Electrophysiology was employed to measure the excitability of glutamatergic neurons and IAHP.Results: Fear conditioning decreased the levels of synaptic SK2 channels in the BLA, which were restored following fear extinction. Notably, reduced expression of synaptic SK2 channels in the BLA during fear conditioning was caused by the increased activity of protein kinase A (PKA), while increased levels of synaptic SK2 channels in the BLA during fear extinction were mediated by interactions with membrane‐palmitoylated protein 2 (MPP2).Conclusions: Our results revealed that MPP2 interacts with the SK2 channels and rescues the excitability of glutamatergic neurons by increasing the expression of synaptic SK2 channels in the BLA to promote the normalization of anxiety disorders and provide a new direction for the treatment.